Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Brovit
- Development stage
- Unknown
- Lead developer
- Kaizen Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Brovit is a multi-ingredient nutritional supplement and finished generic formulation manufactured by Kaizen Pharmaceuticals. It is formulated as a capsule containing a combination of the antioxidant lycopene, essential vitamins (A, C, and E), and minerals (Zinc and Selenium). The product is intended for general health prophylaxis and the improvement of immune system function. It is typically distributed in ALU-ALU packaging (10x10 capsules) and serves as a nutraceutical intervention to support cellular health and combat oxidative stress.
- Brand names
- Brovit
02
Targets
RAR (Retinoic acid receptor)
Beyond the preview
Go deeper on Brovit.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Brovit.